feed,title,long_url,short_url
GN:T:AI,First-line Ribociclib-AI Combo Associated with Better Symptom-Related QOL Vs Abemaciclib-AI in HR+/HER2âˆ’ Advanced Breast Cancer - Cancer Network,https://www.cancernetwork.com/view/first-line-ribociclib-ai-combo-associated-with-better-symptom-related-qol-vs-abemaciclib-ai-in-hr-her2-advanced-breast-cancer,https://bit.ly/3tkc2bV
GN:T:AI,Hallucinating to better text translation | MIT News | Massachusetts Institute of Technology - MIT News,https://news.mit.edu/2022/hallucinating-better-text-translation-0606,https://bit.ly/3NuIlgs
